Primary |
Urinary Tract Disorder |
40.0% |
Blood Cholesterol Increased |
20.0% |
Eye Disorder |
20.0% |
Vitamin Supplementation |
20.0% |
|
Blood Cholesterol Increased |
33.3% |
Nausea |
33.3% |
Pollakiuria |
33.3% |
|
Secondary |
Vitamin Supplementation |
37.5% |
Drug Use For Unknown Indication |
25.0% |
Blood Calcium Decreased |
12.5% |
Blood Cholesterol Abnormal |
12.5% |
Thyroid Disorder |
12.5% |
|
Headache |
33.3% |
Myalgia |
33.3% |
Pruritus |
33.3% |
|
Concomitant |
Product Used For Unknown Indication |
14.2% |
Hypertension |
12.2% |
Drug Use For Unknown Indication |
10.2% |
Prophylaxis |
6.4% |
Supplementation Therapy |
5.7% |
Atrial Fibrillation |
5.5% |
Chronic Obstructive Pulmonary Disease |
5.2% |
Macular Degeneration |
5.1% |
Blood Cholesterol Increased |
4.4% |
Asthma |
3.6% |
Vitamin Supplementation |
3.6% |
Medical Diet |
3.3% |
Rheumatoid Arthritis |
3.1% |
Cardiac Disorder |
2.9% |
Osteoporosis |
2.8% |
Routine Health Maintenance |
2.6% |
Diabetes Mellitus |
2.3% |
Gastrooesophageal Reflux Disease |
2.3% |
Pain |
2.3% |
Dry Eye |
2.2% |
|
Dysphonia |
9.9% |
Dyspnoea |
8.5% |
Headache |
7.0% |
Pain |
7.0% |
Drug Ineffective |
5.6% |
Neutropenia |
5.6% |
Pain In Extremity |
5.6% |
Pyrexia |
5.6% |
Vomiting |
5.6% |
Death |
4.2% |
Dizziness |
4.2% |
Macular Degeneration |
4.2% |
Paraesthesia |
4.2% |
Product Quality Issue |
4.2% |
Upper Gastrointestinal Haemorrhage |
4.2% |
Arthralgia |
2.8% |
Candidiasis |
2.8% |
Decreased Appetite |
2.8% |
Electrocardiogram Qt Prolonged |
2.8% |
Flatulence |
2.8% |
|
Interacting |
Epilepsy |
50.0% |
Vitamin Supplementation |
50.0% |
|
|